Regeneron to Buy 23andMe for $256M Amid Bankruptcy
Regeneron acquires 23andMe's consumer genetics assets for $256M after 23andMe's Chapter 11 bankruptcy. 🧬
Cheddar News
51 views • May 24, 2025
About this video
Regeneron Pharmaceuticals has agreed to acquire 23andMe’s consumer genetics business and assets for $256 million, following 23andMe’s Chapter 11 bankruptcy.
Video Information
Views
51
Duration
0:38
Published
May 24, 2025
Related Trending Topics
LIVE TRENDSRelated trending topics. Click any trend to explore more videos.